get a key
steadybase-$ company APYX
account_id none on file
legal_name Apyx Medical Corp
ticker APYX
cik 719135
domain apyxmedical.com
entry_point_account_id none on file
name Apyx Medical Corporation
exchange Nasdaq
sector Health Care
hq Clearwater, FL, United States
calls 4 filings 24 executives 13 family 0
why_nownone on file
calls
In addition to Tara's guidance-related comments, I want to emphasize that we are very focused on prudent expense management to maximize our resources during this challenging time.

Nov 10, 2022 / receipt, needs a key / Charlie Goodwin, CEO | earnings call 2022-11-10 | transcript 98fd530a-d675-4cf7-9ded-d65fa3258bb8 | chars 19586-19765 | segment 19

The increase in operating expenses year-over-year was driven by an increase in salaries and related costs of $.5 million, which was primarily due to higher compensation and benefits and stock compensation expense. an increase in professional services of $0.5 million, which was primarily due to higher legal fees, and an increase in selling, general, and administrative expenses of 0.3 million, which was primarily due to the return of in-person internal training events and trade shows in 2022.

Aug 11, 2022 / receipt, needs a key / Tara Sem, CFO | earnings call 2022-08-11 | transcript 12c52cdb-6dd7-4544-bac1-ff5e96fc965b | chars 13346-13841 | segment 13

The increase in selling, general, and administrative expense and professional services was primarily driven by the return of in-person internal training events and trade shows as well as our in-person users meeting in 2022.

May 12, 2022 / receipt, needs a key / Tara, CFO | earnings call 2022-05-12 | transcript 6867b8d1-8973-42d0-b458-ec8818ccbfa8 | chars 15033-15256 | segment 15

This normalized OPEX growth expectation excludes $4.3 million of COVID related expense reductions, including discretionary travel and entertainment and other compensation related expenses that benefited our 2020 gap operating expense.

Aug 12, 2021 / receipt, needs a key / Charlie Goodwin, CEO | earnings call 2021-08-12 | transcript 658b1e74-e413-48fd-b375-660a37945596 | chars 17295-17529 | segment 17

filings
The Company continues to expect operating expenses of less than $45.0 million for the year ended December 31, 2026.

ir_statement / Sep 15, 2026 / receipt

Total revenue in the range of $59.0 million to $60.0 million, compared with $52.8 million reported for the year ended December 31, 2025.

ir_statement / Sep 15, 2026 / receipt

Continue to develop network outside of U.S.

ir_statement / Sep 15, 2026 / receipt

Manage expenses while driving progress towards profitability

ir_statement / Sep 15, 2026 / receipt

Anticipate operating expenses to be below $40 million in 2025

ir_statement / Sep 15, 2026 / receipt

Identified over $4M in additional cost savings

ir_statement / Sep 15, 2026 / receipt

Implemented a cost saving restructuring program that included an organizational reduction in force to better focus, optimize and streamline operations:

ir_statement / Sep 15, 2026 / receipt

Reduced U.S. workforce by nearly 25%, with estimated annualized future cost savings of ~$4.3M

ir_statement / Sep 15, 2026 / receipt

Anticipate operating expenses to be below $40 million in 2025

ir_statement / Aug 25, 2026 / receipt

Identified over $4M in additional cost savings

ir_statement / Aug 25, 2026 / receipt

Implemented a cost saving restructuring program that included an organizational reduction in force to better focus, optimize and streamline operations:

ir_statement / Aug 25, 2026 / receipt

Reduced U.S. workforce by nearly 25%, with estimated annualized future cost savings of ~$4.3M

ir_statement / Aug 25, 2026 / receipt

executives
Charles D. Goodwin II director - receipt
Charlie Goodwin CEO - receipt
Craig A. Swandal director - receipt
J. Robert Saron President - receipt
Jay Ewers Interim Chief Financial Officer - receipt
Matthew Hill Chief Financial Officer - receipt
Minnie Baylor-Henry director - receipt
Peter Donato Executive Vice President - receipt
Shawn D. Roman Chief Operating Officer - receipt
Tara Harris Semb Chief Financial Officer - receipt
Tara Sam CFO - receipt
Tara Sem CFO - receipt
Wendy Levine director - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changes
2025-02-06 Chief Operating Officer, appointed sec_8k
2024-11-08 Chief Operating Officer, appointed sec_8k
2023-11-28 Chief Financial Officer, appointed sec_8k
2022-03-21 director, appointed sec_8k
2022-03-21 director, appointed sec_8k
2021-08-30 director, appointed sec_8k
2019-08-07 director, appointed sec_8k
2018-12-17 Chief Financial Officer, appointed sec_8k
2018-03-14 director, appointed sec_8k
2017-12-18 director, appointed sec_8k
2015-06-15 Interim Chief Financial Officer, appointed sec_8k
2015-05-08 director, departed sec_8k
mcp_package_hint
steadybase-$